Cardiome Pharma Corp.CRME was a big mover last session, as the company saw its shares rise over 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.95 to $3.10 in the past one-month time frame.
None of the estimates for this stock were revised in the last 30 days and the Zacks Consensus Estimate also remained unchanged. Friday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Currently, Cardiome Pharma carries a Zacks Rank #4 (Sell).
Cardiome Pharma Corporation Price
A better-ranked stock in the same industry is Infinity Pharmaceuticals, Inc. INFI , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .
Zacks' Hidden Trades
While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?
Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum...from stocks under $10 to ETF to option movers...from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trade >>
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.